ABIONYX Pharma

A new generation biotech company

Balma, France · $39.0M raised

Headquarters
Balma
Employees
11–50
Business Model
B2B
Total Funding
$39.0M
Last Round
$33.0M Corporate RoundMay 2026
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 3 investors for this company. The full record is or through the API.

About

ABIONYX Pharma is a next-generation biotech company developing innovative therapies for indications with no existing or effective treatment, including sepsis, renal disease, and ophthalmology. The company leverages bioengineered HDL nanoparticles and apoA-I-based platforms, including CER-001 and ABNX-100, as breakthrough biotherapeutics and targeted drug delivery vectors.

Summary

ABIONYX Pharma is a Biotech company based in Balma, France. It has raised $39.0M in total across 5 rounds, most recently a $33.0M Corporate Round in May 2026. Investors include Sofinnova Partners, Alta Partners and EDF Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundMay 2026
$33.0M

Sign up to see all 5 events

Funding: Seed through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ABIONYX Pharma on Indexed.vc
<a href="https://indexed.vc/companies/abionyx-pharma"><img src="https://indexed.vc/api/badge/company/abionyx-pharma" alt="ABIONYX Pharma on Indexed.vc" width="260" height="76" /></a>